Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMD vs MRNA✓SelectedUSD · MRNAAMD vs MRNA performance historyLatest closeAs of-13.25%11/20
Stock and ETF performance explorer

AMD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+106.0%
MRNA return
+697.5%
Excess return
-591.6%
Maximum drawdown
-37.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-13.2%-2.2%-11.1%-13.2%
7D-20.5%-12.7%-7.8%-20.3%
30D-23.2%-20.7%-2.5%-22.8%
3M-9.6%+46.3%-55.9%-9.8%
6M-5.2%+305.2%-310.4%-16.1%
YTD+98.2%+561.2%-463.1%+58.6%
1Y+106.0%+772.1%-666.1%+53.1%
All+106.0%+697.5%-591.6%+53.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling